An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

Traggiai, Elisabetta, Becker, Stephan, Subbarao, Kanta, Kolesnikova, Larissa, Uematsu, Yasushi, Gismondo, Maria Rita, Murphy, Brian R, Rappuoli, Rino +1 more·2004·Nature Medicine

Cited by (690)

Items 301–400 of 690

  1. Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin
    Antonino Cassotta, Philipp Paparoditis, Roger Geiger, Ramgopal R. Mettu, Samuel J. Landry, Alessia Donati, Marco Benevento, Mathilde Foglierini, David J. M. Lewis, Antonio Lanzavecchia et al. · 2020 · The Journal of Experimental Medicine
  2. Max Bergmann lecture Protein epitope mimetics in the age of structural vaccinology
    John A. Robinson · 2013 · Journal of Peptide Science
  3. Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2
    Pravas Kumar Baral, Jiang Yin, Michael N.G. James · 2021 · International Journal of Biological Macromolecules
  4. Exploiting Highly Ordered Subnanoliter Volume Microcapillaries as Microtools for the Analysis of Antibody Producing Cells
    Valerie Fitzgerald, Brian Manning, Barry O’Donnell, Brian O’Reilly, Dermot O’Sullivan, Richard J O’Kennedy, Paul Leonard · 2014 · Analytical Chemistry
  5. Rapid Structural Characterization of Human Antibody–Antigen Complexes through Experimentally Validated Computational Docking
    Luca Simonelli, Martina Beltramello, Zinaida Yudina, Annalisa Macagno, Luigi Calzolai, Luca Varani · 2010 · Journal of Molecular Biology
  6. A new dawn for monoclonal antibodies against antimicrobial resistant bacteria
    Marco Troisi, Eleonora Marini, Valentina Abbiento, Samuele Stazzoni, Emanuele Andreano, Rino Rappuoli · 2022 · Frontiers in Microbiology
  7. Characterization of a Human Platelet Antigen-1a–Specific Monoclonal Antibody Derived from a B Cell from a Woman Alloimmunized in Pregnancy
    Mariana Eksteen, Heidi Tiller, Maria Averina, Gøril Heide, Mette Kjær, Cédric Ghevaert, Terje Einar Michaelsen, Øistein Ihle, Anne Husebekk, Bjørn R. Skogen et al. · 2015 · The Journal of Immunology
  8. Substitution at Aspartic Acid 1128 in the SARS Coronavirus Spike Glycoprotein Mediates Escape from a S2 Domain-Targeting Neutralizing Monoclonal Antibody
    Oi-Wing Ng, Choong Tat Keng, Cynthia Sau-Wai Leung, Malik J. S. Peiris, Leo L. M. Poon, Yee‐Joo Tan · 2014 · PLoS ONE
  9. Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome
    Davide Corti, Nadia Passini, Antonio Lanzavecchia, Maria Cristina Fleischmann Alves Zambon · 2016 · Journal of Infection and Public Health
  10. COVID-19: Significance of antibodies
    Sara Assadiasl, Yousef Fatahi, Mahdi Zavvar, Mohammad Hossein Nicknam · 2020 · Human Antibodies
  11. Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses
    Jun Huang, Rui Ma, Chang You Wu · 2006 · Vaccine
  12. Nanoscale integration of single cell biologics discovery processes using optofluidic manipulation and monitoring
    Marsela Jorgolli, Tanner Nevill, Aaron G. Winters, Irwin Chen, Su Chong, Fen‐Fen Lin, Marissa L. Mock, Ching Chen, Kim Le, Christopher Tan et al. · 2019 · Biotechnology and Bioengineering
  13. Amplification and Analysis of cDNA Generated from a Single Cell by 5′-RACE: Application to Isolation of Antibody Heavy and Light Chain Variable Gene Sequences from Single B Cells
    Tatsuhiko Ozawa, Hiroyuki Kishi, Atsushi Muraguchi · 2006 · BioTechniques
  14. The Application of Machine Learning on Antibody Discovery and Optimization
    Jiayao Zheng, Yu Wang, Qianying Liang, Lun Cui, Liqun Wang · 2024 · Molecules
  15. Critical assessment of human antibody generation in humanized mouse models
    Julien Villaudy, Remko Schotte, Nicolas Legrand, Hergen Spits · 2014 · Journal of Immunological Methods
  16. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review
    Akram Yarmohammadi, Mostafa Yarmohammadi, Sajad Fakhri, Haroon Zaman Khan · 2020 · European Journal of Pharmacology
  17. Targeting the Immune System in Non–Small-Cell Lung Cancer: Bridging the Gap Between Promising Concept and Therapeutic Reality
    Ronan Joseph Kelly, James L. Gulley, Giuseppe Giaccone · 2010 · Clinical Lung Cancer
  18. Monoclonal antibodies: Principles and applications of immmunodiagnosis and immunotherapy for hepatitis C virus
    Ashraf Abdou Tabll · 2015 · World Journal of Hepatology
  19. Understanding TLR9 action in Epstein-Barr virus infection
    Ludwig Zauner · 2011 · Frontiers in bioscience
  20. Mapping a Neutralizing Epitope on the SARS Coronavirus Spike Protein: Computational Prediction Based on Affinity-selected Peptides
    Natalia Tarnovitski, Leslie J. Matthews, Jianhua Sui, Jonathan M. Gershoni, Wayne Anthony Marasco · 2006 · Journal of Molecular Biology
  21. Reassessing therapeutic antibodies for neglected and tropical diseases
    Rob Hooft van Huijsduijnen, Somei Kojima, Dee A. Carter, Hisafumi Okabe, Akihide Sato, Wataru Akahata, Timothy N. C. Wells, Kei Katsuno · 2020 · PLoS neglected tropical diseases
  22. The Role of Single-Cell Technology in the Study and Control of Infectious Diseases
    Weikang Nicholas Lin, Matthew Zirui Tay, Ri Lu, Yi Liu, Chia‐Hung Chen, Lih Feng Cheow · 2020 · Cells
  23. What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
    Jin‐Hong Yoo · 2021 · Journal of Korean Medical Science
  24. Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine
    Antonio Cassone, Antonella Torosantucci · 2006 · Expert Review of Vaccines
  25. A Human Monoclonal Antibody against Hepatitis B Surface Antigen with Potent Neutralizing Activity
    Antonella Cerino, Corinna M. Bremer, Dieter Glebe, Mario Umberto Mondelli · 2015 · PLoS ONE
  26. Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges
    Jean‐Luc Teillaud · 2005 · Expert Opinion on Biological Therapy
  27. Modern Antibody Technology: The Impact on Drug Development
    Simon E. Moroney, Andreas Plückthun · 2005 · Wiley eBooks
  28. Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention
    K. -S. Yeung, Gregory A. Yamanaka, Nicholas A. Meanwell · 2006 · Medicinal Research Reviews
  29. Middle East respiratory syndrome vaccines
    Stanley M. Perlman, Rahul Vijay · 2016 · International Journal of Infectious Diseases
  30. Increased Antibody Affinity Confers Broad In Vitro Protection against Escape Mutants of Severe Acute Respiratory Syndrome Coronavirus
    Mridula Rani, Meagan E. Deming, Eric Donaldson, Thomas J. Van Blarcom, Ralph Steven Baric, Brent L. Iverson, George Georgiou · 2012 · Journal of Virology
  31. The Human IgE Repertoire
    Elisabeth Gadermaier, Mattias Levin, Sabine Flicker, Mats Ohlin · 2013 · International Archives of Allergy and Immunology
  32. Expression Cloning and Production of Human Heavy-Chain-Only Antibodies from Murine Transgenic Plasma Cells
    Dubravka Drabek, Rick Janssens, Ernie de Boer, Rik Rademaker, Johannes Kloess, John James Skehel, Frank G. Grosveld · 2016 · Frontiers in Immunology
  33. Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxins
    Sharad P. Adekar, R. Mark Jones, Mohammad D. Elias, Fetweh H. Al‐Saleem, Michael J. Root, Lance L. Simpson, Scott K. Dessain · 2008 · Journal of Immunological Methods
  34. Specificities of broadly neutralizing anti-HIV-1 sera
    James Μ. Binley · 2009 · Current Opinion in HIV and AIDS
  35. Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome
    Aleš Janda, Klaus Schwarz, Mirjam van der Burg, Werner Vach, Hanna IJspeert, Myriam Ricarda Lorenz, Magdeldin Elgizouli, Kathrin Pieper, Paul Fisch, Joachim Hagel et al. · 2016 · Blood
  36. PRESCIENT: platform for the rapid evaluation of antibody success using integrated microfluidics enabled technology
    Jose A. Wippold, Han Wang, Joseph D. Tingling, Julian L. Leibowitz, Paul de Figueiredo, Arum Han · 2020 · Lab on a Chip
  37. Strain-Transcending Fc-Dependent Killing ofPlasmodium falciparumby Merozoite Surface Protein 2 Allele-Specific Human Antibodies
    Janine Stubbs, Sope Omowale Olugbile, Saidou Balam, Jacques Simporè, Giampietro Corradin, Antonio Lanzavecchia · 2010 · Infection and Immunity
  38. Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses
    Zhongyu Zhu, Antony S. Dimitrov, Samitabh Chakraborti, Dimana Dimitrova, Xiaodong Xiao, Christopher C. Broder, Dimiter Stanchev Dimitrov · 2006 · Expert Review of Anti-infective Therapy
  39. Recent advances in antibody‐based immunotherapy strategies for COVID‐19
    Abdolreza Esmaeilzadeh, Samaneh Miri Rostami, Pegah Moharrami Yeganeh, Safa Tahmasebi, Majid Ahmadi · 2021 · Journal of Cellular Biochemistry
  40. An overview on Severe Acute Respiratory Syndrome (SARS)
    David S.C. Hui · 2005 · Monaldi Archives for Chest Disease
  41. TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism
    Johannes Noack, Marc Jordi, Ludwig Zauner, Davide Alessi, Andrea Burch, Marianne Tinguely, Martin Hersberger, Michele Bernasconi, David Nadal · 2012 · Cell Death and Disease
  42. High-throughput antibody production
    Ross Chambers · 2004 · Current Opinion in Chemical Biology
  43. Therapeutic modalities and novel approaches in regenerative medicine for COVID-19
    Roya Ramezankhani, Roya Solhi, Arash Memarnejadian, Fatemeharefeh Nami, Seyed Mohammad Reza Hashemian, Tine Tricot, Massoud Vosough, Catherine M. Verfaillie · 2020 · International Journal of Antimicrobial Agents
  44. The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review
    Subham Das, Anu Kunnath Ramachandran, Sumit Birangal, Saleem Akbar, Bahar Ahmed, Alex Joseph · 2021 · Medicine in Drug Discovery
  45. MAC-CCD system: a novel lymphocyte microwell-array chip system equipped with CCD scanner to generate human monoclonal antibodies against influenza virus
    Tatsuhiko Ozawa, K. Kinoshita, Shinichi Kadowaki, Kazuto Tajiri, S. Kondo, Ritsu Honda, M. Ikemoto, L. Piao, A. Morisato, Kenkichi Fukurotani et al. · 2008 · Lab on a Chip
  46. Identification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent Elicitation
    Crystal Sao‐Fong Cheung, Alexander Fruehwirth, Philipp Paparoditis, Chen‐Hsiang Shen, Mathilde Foglierini, Michael Gordon Joyce, Kwanyee Leung, Luca Piccoli, Reda Rawi, Chiara Silacci-Fregni et al. · 2020 · Cell Reports
  47. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
    Nina Marí Gual Pimenta de Queiroz, Fabio Vitarelli Marinho, Marcelo Chagas, Luciana C. C. Leite, E. Jane Homan, Mariana T. Q. de Magalhães, Sergio Costa Oliveira · 2020 · Microbes and Infection
  48. Epitope Mapping of Broadly Neutralizing HIV-2 Human Monoclonal Antibodies
    Rui Kong, Hui Li, Ivelin S. Georgiev, Anita Changela, Frédéric Bibollet‐Ruche, Julie M. Decker, Sarah Rowland‐Jones, Assan Jaye, Yongjun Guan, George K. Lewis et al. · 2012 · Journal of Virology
  49. Lambda Light Chain Revision in the Human Intestinal IgA Response
    Wen Su, John Nicholas Gordon, Francesca Barone, Laurent Boursier, Wayne Turnbull, Surangi Mendis, Deborah K. Dunn‐Walters, Jo Spencer · 2008 · The Journal of Immunology
  50. Host Immune Responses to SARS Coronavirus in Humans
    Chris Ka-fai Li, Xiao‐Ning Xu · 2009 · Springer eBooks
  51. Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine
    Yasuko Tsunetsugu‐Yokota, Kazuo Ohnishi, Toshitada Takemori · 2006 · Reviews in Medical Virology
  52. Coronavirus disease 2019—Historical context, virology, pathogenesis, immunotherapy, and vaccine development
    Sayeh Ezzikouri, Jalal Nourlil, Soumaya Benjelloun, Michinori Kohara, Kyoko Tsukiyama–Kohara · 2020 · Human Vaccines & Immunotherapeutics
  53. Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study
    Poul Erik Jensen, Clemens Warnke, Kathleen Ingenhoven, Luca Piccoli, Marcia Gasis, Christina E. Hermanrud, Blanca Maria Fernandez-Rodriguez, Malin Lundkvist Ryner, Daniel Kramer, Jenny Link et al. · 2018 · Journal of Neuroimmunology
  54. Predicting Vaccine Responsiveness
    Scott Dexter Boyd, Katherine Jackson · 2015 · Cell Host & Microbe
  55. Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review
    Shukur Wasman Smail, Muhammad Saeed, Twana Alkasalias, Zhikal Omar Khudhur, Delan Ameen Younus, Mustafa Fahmi Rajab, Wayel Habib Abdulahad, Hafiz Iftikhar Hussain, Kamal Niaz, Muhammad Safdar · 2021 · Food and Chemical Toxicology
  56. Identification and Development of Therapeutics for COVID-19
    Halie M. Rando, Nils Wellhausen, Soumita Ghosh, Alexandra J. Lee, Anna Ada Dattoli, Fengling Hu, James Brian Byrd, Diane N. Rafizadeh, Ronan Lordan, Yanjun Qi et al. · 2021 · mSystems
  57. Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative
    Ahmed O. Shalash, Waleed M. Hussein, Mariusz Skwarczyński, István Tóth · 2021 · Advanced Science
  58. Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies
    Irene Sanjuan Nandin, Carol Ho-Yan Fong, Cecilia Deantonio, Juan Andres Torreno-Pina, Simone Pecetta, Paula Maldonado Villavicencio, Francesca Gasparrini, José Ordovás-Montañés, Samuel W. Kazer, Svend Kjær et al. · 2017 · The Journal of Experimental Medicine
  59. Animal Models for Sars
    Anjeanette Roberts, Kanta Subbarao · 2006 · Advances in experimental medicine and biology
  60. Passive immunization with influenza haemagglutinin specific monoclonal antibodies
    Rajeev Rudraraju, Kanta Subbarao · 2018 · Human Vaccines & Immunotherapeutics
  61. Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires
    Hemangi B. Shah, Kenneth Smith, Jonathan D. Wren, Carol F. Webb, Jimmy D. Ballard, Rebecka L. Bourn, Judith A. James, Mark L. Lang · 2019 · Frontiers in Immunology
  62. Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review)
    Jiachen Lu, Jianing Ding, Zhaoxia Liu, Tingtao Chen · 2022 · International Journal of Oncology
  63. Human Immunoglobulin Repertoires against Tetanus Toxoid Contain a Large and Diverse Fraction of High-Affinity Promiscuous VH Genes
    John de Kruif, Arjen Kramer, Therèse Visser, Carina Clements, Roy Nijhuis, Freek Cox, Vanessa Zondag-van der Zande, Renate Smit, Daniel Damazio Pinto, Mark Throsby et al. · 2009 · Journal of Molecular Biology
  64. Genetic manipulation of B cells for the isolation of rare therapeutic antibodies from the human repertoire
    Mark J. Kwakkenbos, Arjen Q. Bakker, Pauline M. van Helden, Koen Wagner, Etsuko Yasuda, Hergen Spits, Tim Beaumont · 2013 · Methods
  65. Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
    Te-hui W. Chou, Shixia Wang, Pavlo V. Sakhatskyy, Innocent Mboudoudjeck, John M. Lawrence, Song Huang, Scott Coley, Yang Baoan, Jiaming Li, Qingyu Zhu et al. · 2005 · Virology
  66. A potent synthetic nanobody targets RBD and protects mice from SARS-CoV-2 infection
    Tingting Li, Hongmin Cai, Hebang Yao, Bingjie Zhou, Ning Zhang, Yuhuan Gong, Yapei Zhao, Quan Shen, Wenming Qin, Cedric A.J. Hutter et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  67. Coronaviruses pandemics: Can neutralizing antibodies help?
    Phuoc Bao Viet Tong, Li‐Yun Lin, Tuan Hiep Tran · 2020 · Life Sciences
  68. Precision engineering for localization, validation, and modification of allergenic epitopes
    Anna Pomés, Scott Alan Smith, M. Chruszcz, Geoffrey A. Mueller, Nicole F. Brackett, Martin D. Chapman · 2024 · Journal of Allergy and Clinical Immunology
  69. The peculiar features, diversity and impact of citrulline-reactive autoantibodies
    Bruno Raposo, Lars Klareskog, William H. Robinson, Vivianne Malmström, Caroline Grönwall · 2024 · Nature Reviews Rheumatology
  70. A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C
    Rajesh Kumar, Raiees Andrabi, Ashutosh Tiwari, Somi Sankaran Prakash, Naveet Wig, Durgashree Dutta, Anurag Sankhyan, Lubina Khan, Subrata Sinha, Kalpana Luthra · 2012 · BMC Biotechnology
  71. Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11
    Man Wai Cheng, Ceci W.L. Chan, Randy Chi Fai Cheung, Rama Kamesh Bikkavilli, Qi Zhao, Shannon Wing Ngor Au, Paul K.S. Chan, Susanna S.T. Lee, Gregory Yin-Ming Cheng, Walter K.K. Ho et al. · 2005 · Biochemical and Biophysical Research Communications
  72. A novel method for making human monoclonal antibodies
    Judith Fraussen, Kathleen Vrolix, Pilar Martínez‐Martínez, Mario H. Losen, Els V. Meulemans, Marc H. De Baets, Piet Stinissen, Veerle A Somers · 2010 · Journal of Autoimmunity
  73. Development of a vaccine against the newly emerging COVID-19 virus based on the receptor binding domain displayed on virus-like particles
    Lisha Zha, Hongxin Zhao, Mona O. Mohsen, Liang Hong, Yuhang Zhou, Zehua Li, Hongquan Chen, Xuelan Liu, Xinyue Chang, Jie Zhang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  74. Severe Acute Respiratory Syndrome (SARS)
    Malik J. S. Peiris, Yi Guan, Leo L. M. Poon, Vincent Chi‐Chung Cheng, John Malcolm Nicholls, Kwok-Yung Yuen · 2008 · Elsevier eBooks
  75. Co-transplantation of human fetal thymus, bone and CD34+ cells into young adult immunodeficient NOD/SCID IL2Rγnull mice optimizes humanized mice that mount adaptive antibody responses
    Yun Shin Chung, Jin Kyung Son, Bongkum Choi, Sung-Yeon Joo, Yong Soo Lee, Jae Berm Park, Hana Moon, Tae Jin Kim, Se Ho Kim, Seokmann Hong et al. · 2015 · Clinical Immunology
  76. Inhibition of infection caused by severe acute respiratory syndrome-associated coronavirus by equine neutralizing antibody in aged mice
    Lili Zhou, Bing Ni, Deyan Luo, Guangyu Zhao, Zhengcai Jia, Liangyan Zhang, Zhihua Lin, Li Wang, Zhang Songle, Li Xing et al. · 2006 · International Immunopharmacology
  77. Dissecting human antibody responses: useful, basic and surprising findings
    Antonio Lanzavecchia · 2018 · EMBO Molecular Medicine
  78. An Effective Neutralizing Antibody Against Influenza Virus H1N1 from Human B Cells
    Chien‐Chung Lee, Chih-Ya Yang, Li‐Ling Lin, Tzu‐Ping Ko, Alarng Chang, Stanley Shi-Chung Chang, Andrew H.‐J. Wang · 2019 · Scientific Reports
  79. Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection
    Sherif Aly El-Kafrawy, Aymn T. Abbas, Sayed Sartaj Sohrab, Ashraf Abdou Tabll, Ahmed M. Hassan, Naoko Iwata‐Yoshikawa, Noriyo Nagata, Esam I. Azhar · 2021 · Pharmaceuticals
  80. Comprehensive Antibody Epitope Mapping of the Nucleocapsid Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Insight into the Humoral Immunity of SARS
    Yunfei Liang, Ying Wan, Liwen Qiu, Jingran Zhou, Bing Ni, Bo Guo, Qiang Zou, Liyun Zou, Wei Zhou, Zhengcai Jia et al. · 2005 · Clinical Chemistry
  81. Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies
    Christoph Kreer, Henning Gruell, Thierry Mora, Aleksandra M. Walczak, Florian Klein · 2020 · Vaccines
  82. The COVID-19 pandemic: biological evolution, treatment options and consequences
    Sovik Das, Swati Das, Makarand M. Ghangrekar · 2020 · Innovative Infrastructure Solutions
  83. SARS-CoV-2 infection and immune responses
    Rakhi Harne, Brittany Williams, Hazem F. M. Abdelaal, Susan L. Baldwin, Rhea N. Coler · 2023 · AIMS Microbiology
  84. Production of Human Monoclonal Antibodies by the Epstein–Barr Virus Method
    Michael O Steinitz · 2013 · Methods in molecular biology
  85. Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals
    Raiees Andrabi, Constance A. U. Williams, Xiaohong Wang, Liuzhe Li, Alok Kumar Choudhary, Naveet Wig, Ashutosh Biswas, Kalpana Luthra, Arthur J. Nadas, Michael S. Seaman et al. · 2013 · Virology
  86. Antibody responses in primary HIV-1 infection
    Simon D. W. Frost, Alexandra Trkola, Huldrych F. Günthard, Douglas D. Richman · 2008 · Current Opinion in HIV and AIDS
  87. High throughput cellular screens to interrogate the human T and B cell repertoires
    Davide Corti, Federica Sallusto, Antonio Lanzavecchia · 2011 · Current Opinion in Immunology
  88. Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections
    Marta Maria Gaglia · 2021 · Virology Journal
  89. Neutralizing antibody against severe acute respiratory syndrome (SARS)‐coronavirus spike is highly effective for the protection of mice in the murine SARS model
    Koji Ishii, Hideki Hasegawa, Noriyo Nagata, Yasushi Ami, Shuetsu Fukushi, Fumihiro Taguchi, Yasuko Tsunetsugu‐Yokota · 2008 · Microbiology and Immunology
  90. Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells
    Ada Funaro, Giorgio Gribaudo, Anna Luganini, Erika Ortolan, Nicola Lo Buono, Elisa Vicenzi, Luca Cassetta, Santo Landolfo, Richard J. Buick, Luca Falciola et al. · 2008 · BMC Biotechnology
  91. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection
    Gayathri Krishna, Vinod Soman Pillai, Mohanan Valiya Veettil · 2020 · European Journal of Pharmacology
  92. Autoreactive antibodies control blood glucose by regulating insulin homeostasis
    Timm Amendt, Gabriele Allies, Antonella Nicolò, Omar El Ayoubi, Marc Young, Tamás Rőszer, Corinna S. Setz, Klaus Warnatz, Hassan Jumaa · 2022 · Proceedings of the National Academy of Sciences
  93. Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
    Leonardo Fontoura Ormundo, Carolina Thome Barreto, Lilian Rumi Tsuruta · 2023 · Viruses
  94. Clonal analysis of SepSecS-specific B and T cells in autoimmune hepatitis
    Michael Kramer, Federico Mele, Sandra Jovic, Blanca Maria Fernandez, David Jarrossay, Jun Siong Low, Christiane Sokollik, Magdalena Filipowicz Sinnreich, Sylvie Ferrari-Lacraz, Giorgina Mieli‐Vergani et al. · 2025 · Journal of Clinical Investigation
  95. Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome
    A Marmont, Francesca Gualandi, Domenico Occhini, Fabio Morandi, Elisa Ferretti, Annalisa Pezzolo, Paolo Strada, Jean Louis Ravetti, Vito Pistoia, Anna Falanga et al. · 2006 · Autoimmunity
  96. SARS-CoV-2: A New Song Recalls an Old Melody
    Kanta Subbarao · 2020 · Cell Host & Microbe
  97. Protective Human Anti-Poxvirus Monoclonal Antibodies Are Generated from Rare Memory B Cells Isolated by Multicolor Antigen Tetramers
    Xiuling Gu, Yufan Zhang, Wei Jiang, Dongfang Wang, Jiao Lu, Guanglei Gu, Cheng‐Feng Qin, Min Fang · 2022 · Vaccines
  98. Severe Acute Respiratory Syndrome Coronavirus Entry as a Target of Antiviral Therapies
    Jens H. Kuhn, Wenhui Li, Sheli R. Radoshitzky, Hyeryun Choe, Michael Farzan · 2007 · Antiviral Therapy
  99. Protection from Infection with Severe Acute Respiratory Syndrome Coronavirus in a Chinese Hamster Model by Equine Neutralizing F(ab′) 2
    Deyan Luo, Bing Ni, Guangyu Zhao, Zhengcai Jia, Lili Zhou, Marek Pacal, Liangyan Zhang, Zhang Songle, Li Xing, Zhihua Lin et al. · 2007 · Viral Immunology
  100. Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
    Arnaud John Kombe Kombe, Ayesha Zahid, Ahmed Mohammed, Ronghua Shi, Tengchuan Jin · 2021 · Frontiers in Molecular Biosciences